Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Developed by Eli Lilly, Tirzepatide was approved by the US FDA under the brand name Mounjaro, as a first-in-class drug (Chavda et al., 2022)
GLP-1 receptor agonists superior for countering weight regain after bariatric surgery Adults with obesity who regained weight after bariatric surgery saw more effective weight loss with GLP-1 receptor agonist therapy compared with other weight-loss regimens, according to data published in Obesity
But really we have no idea how this plays out in [pregnant] humans, and we wont have that data for years. Despite the lack of clarity on what this drug could do to women, the concerns have not been relayed in advertising in the US or in media coverage
Hypoglycemia is possible in diabetes patients
Dueregger A, Schpf B, Eder T, Hfer J, Gnaiger E, Aufinger A, Kenner L, Perktold B, Ramoner R, Klocker H, Eder IE (2015) Differential utilization of dietary fatty acids in benign and malignant cells of the prostate
